Romagnoli Stefano
Professor, Department of Animal Medicine, Production and Health, University of Padova, Italy
J Feline Med Surg. 2015 Sep;17(9):743-52. doi: 10.1177/1098612X15594987.
The high fertility rate of cats means that methods to control feline reproduction are a requirement for cat breeders and pet owners, as well as for those involved in the management of feral cat populations. Progestins continue to be used to prevent queens from cycling, and also as an adjunct or alternative to surgical sterilization within trap-neuter-return (TNR) programs.
A considerable body of information exists on megestrol acetate (MA) and medroxyprogesterone acetate (MPA), thanks to the many studies and case reports published in the scientific literature over the past 50 years documenting their clinical use in cats. Comparatively less is known about the use in cats of more recent progestins such as levonorgestrel, proligestone, delmadinone, chlormadinone and altrenogest.
DOSING, SAFETY AND EFFICACY: Based on a combination of dose, frequency and duration of treatment, MA can be categorized into low (0.625 mg/kg/week for up to 30 weeks), medium (0.625 mg/kg q24h for 1 week or q48h for up to 2 weeks) and high (0.625 mg/kg q24h or q48h for several weeks, or weekly for months or years) dosages. Studies suggest that low dosages can be used relatively safely in cats, while higher dosages increase the risk and severity of adverse reactions. Early work showing that an oral MPA dosage of 0.01 mg/kg administered q24h for 12 months suppresses oestrus in queens effectively and safely has not been considered, and much higher MPA dosages (>6.25 mg/kg q24h) have been used in cats over the past 40 years.
Progestins should always be used with caution. Using the lowest possible dosages, MA and MPA may, however, continue to be used safely in pet queens as well as (in conjunction with TNR programs) for the control of feral cat colonies. More recent progestins appear to be effective and safe, albeit their efficacy and safety need to be further investigated.
猫的高繁殖率意味着控制猫繁殖的方法是猫繁育者、宠物主人以及参与流浪猫种群管理的人员所需要的。孕激素继续被用于防止母猫发情,并且在诱捕-绝育-放归(TNR)计划中作为手术绝育的辅助手段或替代方法。
由于过去50年科学文献中发表了许多关于醋酸甲地孕酮(MA)和醋酸甲羟孕酮(MPA)在猫临床应用的研究和病例报告,所以存在大量关于它们的信息。对于较新的孕激素如左炔诺孕酮、炔诺孕酮、地美孕酮、氯地孕酮和烯丙孕素在猫身上的使用,了解相对较少。
给药、安全性和有效性:根据治疗的剂量、频率和持续时间,MA可分为低剂量(0.625毫克/千克/周,持续30周)、中剂量(0.625毫克/千克,每24小时一次,持续1周或每48小时一次,持续2周)和高剂量(0.625毫克/千克,每24小时或每48小时一次,持续数周,或每周一次,持续数月或数年)。研究表明,低剂量在猫身上使用相对安全,而高剂量会增加不良反应的风险和严重程度。早期显示口服MPA剂量为0.01毫克/千克,每24小时一次,持续12个月能有效且安全地抑制母猫发情的研究未被考虑,在过去40年里,猫使用的MPA剂量要高得多(每24小时>6.25毫克/千克)。
使用孕激素时应始终谨慎。然而,使用尽可能低的剂量,MA和MPA仍可在宠物母猫中安全使用,以及(结合TNR计划)用于控制流浪猫群体。较新的孕激素似乎有效且安全,尽管它们的有效性和安全性需要进一步研究。